Skip to content

The Executives BriefBetaGlobal · Daily

Business Technology Science Politics Entertainment For You

Executive DeskStocks Analyzer

Loading the Newsroom

Curating from trusted global sources…

The Executives Brief

Executive intelligence - curated from trusted global sources and refined into a daily strategic briefing.

Topics

Business
Technology
Science
Politics
Entertainment

Regions

Middle East
Americas
Asia
Europe
Africa

The Brief

About
The Executives Club
Register
RSS
Sitemap

© 2026 The Executives Brief. All rights reserved.Curated by editors · Refined by AI · Owned by readers.

Search results

Search · us scrutiny

1 briefing · “us scrutiny”

TrendingChina AI Drug Design Biotech Out Licensing Pharmaceuticals US Scrutiny Dealmaking Healthcare Investment

FromTo

Showing results for “us scrutiny”

AI drug-design out-licensing hits $75B in 2026 as US scrutiny tightens

AI drug-design out-licensing hits $75B in 2026 as US scrutiny tightens

China biotech deals with major multinationals surged to US$75 billion in 2026’s first five months, up from zero before 2020.

By Hessa Al-Faleh·about 14 hours ago· 3 min